Jens Juul Holst
Holst, J.
Holst, J. (Jens)
Holst, J. (Jens), fl. 1991
Holst, Jens Ch
Holst, Jens Juul
VIAF ID: 57323876 (Personal)
Permalink: http://viaf.org/viaf/57323876
Preferred Forms
-
- 100 1 _ ‡a Holst, J.
- 100 1 _ ‡a Holst, J.
-
-
- 100 1 0 ‡a Holst, J. ‡q (Jens)
-
-
- 100 0 _ ‡a Jens Juul Holst
4xx's: Alternate Name Forms (10)
Works
Title | Sources |
---|---|
Die deutschen Ausgrabungen in Karthago | |
Percutaneous estrogen therapy : endometrial response and metabolic effects | |
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. | |
Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting | |
Reflex adrenergic control of endocrine pancreas evoked by unloading of carotid baroreceptors in cats | |
Regulation of gluconeogenesis and ketogenesis during rest and exercise in diabetic subjects and normal men. | |
Regulation of gut hormone secretion. Studies using isolated perfused intestines | |
Regulation of Pancreatic α-Cell Function and Proliferation by Bone Morphogenetic Protein 4 (BMP4) In Vitro. | |
Regulation of urea synthesis during the acute-phase response in rats | |
Regulatory peptides in the lower esophageal sphincter of man | |
Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study. | |
Relationship of glicentin to proglucagon and glucagon in the porcine pancreas | |
Relationships among tonic and episodic aspects of motivation to eat, gut peptides, and weight before and after bariatric surgery | |
Release of galanin from isolated perfused porcine adrenal glands: role of splanchnic nerves | |
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. | |
Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation | |
Release of PYY from pig intestinal mucosa; luminal and neural regulation. | |
Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli | |
Removal of duodenum elicits GLP-1 secretion | |
Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men | |
Repaglinide at a cellular level | |
Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility. | |
Resistant starch and protein intake enhances fat oxidation and feelings of fullness in lean and overweight/obese women | |
Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. | |
Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525 | |
Response to Letter to the Editor: “Hemodynamic Effects of Glucagon: A Literature Review” | |
Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat. | |
Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass - a 2-year follow-up. | |
Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery | |
Role of gastrin-releasing peptide in the neural control of pepsinogen secretion from the pig stomach | |
Role of gastrointestinal hormones in postprandial reduction of bone resorption | |
Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition | |
Role of glucagon in maintenance of euglycemia in fed and fasted rats. | |
Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection | |
Role of nitric oxide in neurally induced pancreatic exocrine secretion in pigs | |
Role of the kidneys in elimination of glucagon, insulin, secretin and somatostatin in the rat | |
Role of the Sympatho-Adrenal System in the Control of Endocrine Pancreas during Haemorrhage in Cats | |
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex | |
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass | |
Roles of the Gut in Glucose Homeostasis | |
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota | |
sabbu | |
Sacubitril/valsartan augments postprandial plasma concentrations of active GLP-1 when combined with sitagliptin in men | |
Safety and Dosing Study of Glucagon-Like Peptide 2 in Children With Intestinal Failure | |
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study | |
SaO009GASTROINTESTINAL MOTILITY IN PATIENTS WITH END-STAGE RENAL DISEASE ON CHRONIC HEMODIALYSIS | |
Satiety scores and satiety hormone response after sucrose-sweetened soft drink compared with isocaloric semi-skimmed milk and with non-caloric soft drink: a controlled trial. | |
Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes | |
Secretin does not inhibit glucagon secretion in pigs | |
Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine | |
Secretin release from the isolated, vascularly perfused pig duodenum | |
Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. | |
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects | |
Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy | |
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? | |
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies | |
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. | |
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes | |
Secretion of pancreastatins from the porcine digestive tract | |
Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets | |
Secretion uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release | |
Secretory effects of secretin on isolated perfused porcine pancreas. | |
Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells | |
Semaglutide seems to be more effective the other GLP-1Ras | |
Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol | |
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes | |
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals | |
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients | |
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism | |
Serum lipase activity and concentration during intravenous infusions of GLP-1 and PYY3-36 and after ad libitum meal ingestion in overweight men. | |
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia | |
Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity: a 1-week randomized clinical trial in healthy young men. | |
Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice | |
Short communication: Promotion of glucagon-like peptide-2 secretion in dairy calves with a bioactive extract from Olea europaea. | |
Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon |